Advanced Health Intelligence Stock EBITDA
| AHIDelisted Stock | USD 3.98 0.18 4.74% |
Advanced Health Intelligence fundamentals help investors to digest information that contributes to Advanced Health's financial success or failures. It also enables traders to predict the movement of Advanced Stock. The fundamental analysis module provides a way to measure Advanced Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Advanced Health stock.
Advanced |
Advanced Health Intelligence Company EBITDA Analysis
Advanced Health's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Advanced Health EBITDA | (18.56 M) |
Most of Advanced Health's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Advanced Health Intelligence is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Advanced Health Intelligence reported earnings before interest,tax, depreciation and amortization of (18.56 Million). This is 102.01% lower than that of the Software sector and significantly lower than that of the Information Technology industry. The ebitda for all United States stocks is 100.48% higher than that of the company.
Advanced EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Advanced Health's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Advanced Health could also be used in its relative valuation, which is a method of valuing Advanced Health by comparing valuation metrics of similar companies.Advanced Health is currently under evaluation in ebitda category among its peers.
Advanced Fundamentals
| Return On Equity | -2.42 | |||
| Return On Asset | -0.66 | |||
| Operating Margin | (40.53) % | |||
| Current Valuation | 12.9 M | |||
| Shares Outstanding | 7.78 M | |||
| Number Of Shares Shorted | 23.52 K | |||
| Price To Book | 8.80 X | |||
| Price To Sales | 20.01 X | |||
| Revenue | 271.01 K | |||
| Gross Profit | (5.77 M) | |||
| EBITDA | (18.56 M) | |||
| Net Income | (20.08 M) | |||
| Cash And Equivalents | 6.01 M | |||
| Cash Per Share | 0.25 X | |||
| Total Debt | 1.16 M | |||
| Debt To Equity | 0.19 % | |||
| Current Ratio | 3.40 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (9.86 M) | |||
| Short Ratio | 2.83 X | |||
| Earnings Per Share | (0.32) X | |||
| Target Price | 12.0 | |||
| Number Of Employees | 12 | |||
| Beta | 1.44 | |||
| Market Capitalization | 13.11 M | |||
| Total Asset | 10.66 M | |||
| Retained Earnings | (62.61 M) | |||
| Working Capital | (2.78 M) | |||
| Z Score | -7.48 | |||
| Net Asset | 10.66 M |
About Advanced Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Advanced Health Intelligence's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Advanced Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Advanced Health Intelligence based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Advanced Stock
If you are still planning to invest in Advanced Health Inte check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Advanced Health's history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |